Kalvista Pharmaceuticals
Price & Volume
Stats
See moreOpen | $13.31 |
Previous Close | $13.36 |
Day Range | $13.13-$13.45 |
52W Range | $7.30-$17.28 |
Market Cap | $662.1M |
Shares Short | 13M |
Financials
See moreRevenue (12 Mos) | $1.4M |
Revenue Growth (YoY) | 30.7% |
Gross Profit (12 Mos) | -$59.4M |
Diluted EPS | -$3.94 |
News
See moreYahoo Finance • 7 days ago
Citizens Touts KalVista Pharmaceuticals, Inc. (KALV) Growth Trajectory on EKTERLY Prospects
Yahoo Finance • 15 days ago
Here are the major earnings before the open Tuesday
Yahoo Finance • 15 days ago
KalVista Pharmaceuticals GAAP EPS of -$0.92, revenue of $13.69M
Yahoo Finance • 15 days ago
KalVista Pharmaceuticals Q3 2026 Earnings Preview
About
CEO | Mr. Benjamin L. Palleiko |
Address | 55 Cambridge Parkway, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 270 |
